FIELD: pharmaceutics.
SUBSTANCE: invention relates to pharmacology, clinical pharmacology and therapy and can be used for correction of protein and lipid status of erythrocytes in ischemic heart disease. Complex therapy is performed for 10 days, wherein daily in the morning at the same time the following are administered: 50 mg of Metoprolol and 8 mg of Perindopril inside, 50 mg/ml Mexicor injections and 2.5 g of Phosphogliv, diluted in 10 ml of injection water, injections, then in the evening at the same time the following components are introduced: 0.5 mg of Nitroglycerine sublingually, 75 mg of Aspirin inside and 2.5 g of Phosphogliv, diluted in 10 ml of injection water, by injection.
EFFECT: invention enables correction of erythrocyte protein and lipid status in ischemic heart disease.
1 cl, 2 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ISCHEMIC HEART DISEASES ACCOMPANYING CHOLESTASIS | 2014 |
|
RU2554333C1 |
| METHOD FOR PREDICTION OF DEGREE OF RISK OF HAEMOLYTIC COMPLICATIONS FOLLOWING CORONARY BYPASS SURGERY | 2013 |
|
RU2542434C1 |
| APPLICATION OF MEXICOR COMBINED WITH STATINS FOR CORONARY HEART MEDICAL TREATMENT OF CORONARY HEART DISEASE | 2005 |
|
RU2325909C2 |
| METHOD FOR TREATING CARDIAC ISCHEMIA DISEASE | 1996 |
|
RU2145487C1 |
| METHOD FOR PREDICTING MODERATE AND PRONOUNCED ERYTHROCYTE LYSIS FOLLOWING CARDIOPULMONARY BYPASS SURGERY | 2013 |
|
RU2552925C1 |
| METHOD FOR SELECTING PATIENTS WITH ISCHEMIC HEART DISEASE AND COMBINED PATHOLOGY AND DIABETES FOR ADDITIONAL PRESCRIPTION OF LASER THERAPY | 2010 |
|
RU2449823C2 |
| METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
| METHOD OF CORONARY DISEASE TREATMENT | 2007 |
|
RU2349297C1 |
| METHOD OF CORONARY DISEASE TREATMENT | 2006 |
|
RU2349296C2 |
| METHOD OF INCREASING OXYGEN TENSION IN BLOOD OF PATIENTS WITH CHRONIC HEART FAILURE | 2013 |
|
RU2526185C1 |
